Demet Kerimoğlu

Demet Kerimoğlu

Auto-generated profile, based on publicly available information

Demet Kerimoğlu

Department of Pulmonary Medicine, Bursa Uludag University, Bursa, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
ADAsli Gorek Dilektasli
Asli Gorek Dilektasli
NÖNilüfer Aylin Acet Öztürk
Nilüfer Aylin Acet Öztürk
DKDemet Kerimoğlu
Demet Kerimoğlu
AOAyten Odabaş
Ayten Odabaş
MYMine Tül Yaman
Mine Tül Yaman
MKMEHMET KARADAĞ
MEHMET KARADAĞ
Background and aim The 4-meter gait speed (4MGS), a functional performance test, is increasingly used to predict health outcomes. This study investigated 4MGS, nutritional status, frailty, and daily living activities in tertiary care pulmonary diseases ward patients. Methods Patients were assessed for nutritional status, activities of daily living, and frailty using the Mini Nutritional Assessment (MNA) Test, Barthel Questionnaire, and FRAIL scale. Those with 4MGS < 1 m/sec were classified as having slow gait speed. Results 80 patients (F/M: 21/59, mean age 58 ± 19) were included. Diagnoses included pneumonia, chronic obstructive pulmonary disease, pleural effusion, and interstitial lung disease. Patients had a 4MGS of 0,74 ± 0,24 m/sn, MNA score of 14.0 [IQR 25–75:11.0–19.8] points, Barthel index of 95 [IQR 25–75:70–100] points, FRAIL scale of 3 [IQR 25–75:1.0–4.0], and a hand-grip strength of 18.8 [IQR 25–75:15.7–25.9] kg. Slow gait speed patients had lower MNA, FRAIL scores, and handgrip strength. Multivariable regression analysis showed that slower gait speed was associated with lower serum protein level (B = 0.013, SE = 0.005, 95% CI: 0.004 to 0.022, p = 0.004), lower hand grip strength (B = -0.002, SE = 0.001, 95% CI: -0.003 to -0.00006, p = 0.041) and malnutrition risk (B = 0.024, SE = 0.007, 95% CI: 0.011 to 0.038, p < 0.001). Discussion and conclusion 4MGS correlates with comorbidities, frailty, grip strength, and nutritional status in hospitalized pulmonary patients. Slow gait patients are more malnourished despite similar age, sex, BMI, and comorbidities.

1 January 2025 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
ADAsli Gorek Dilektasli
Asli Gorek Dilektasli
DKDemet Kerimoğlu
Demet Kerimoğlu
AOAyten Odabaş
Ayten Odabaş
ADAbdurrahman Doğan
Abdurrahman Doğan
AÖArzu Özpehlivan
Arzu Özpehlivan
MKMEHMET KARADAĞ
MEHMET KARADAĞ
Objective: Sarcopenia, the gradual decline in skeletal muscle mass (SMM), strength, and functionality, has negative health consequences such as premature death and disability. It is prevalent in chronic lung disease (CLD). Timely recognition of sarcopenia is required for focused therapy. This study sought to analyze the rate of sarcopenia in patients with CLD and to assess the diagnostic accuracy of the sarcopenia screening tests: the SARC-F, SARC-CalF, and Ishii tests. Materials and Methods: This study comprised individuals diagnosed with CLD and referred for pulmonary rehabilitation. Sarcopenia was evaluated based on the European Working Group on Sarcopenia in Older People criteria (EWGSOP and EWGSOP2), utilizing handgrip strength, SMM index, and gait speed. The diagnostic accuracy of screening tests (SARC-F, SARC-CalF, and Ishii) was assessed by sensitivity, specificity, and the area under the curve (AUC) in the Receiver Ooperating Ccharacteristics. Results: A total of 227 patients, with a mean age of 59.00 Å} 13.98 years, of whom 50.7% had chronic obstructive pulmonary disease (COPD), were included. The rate of probable sarcopenia was 41.2%, confirmed sarcopenia 2.5%, and severe sarcopenia 0.5%. The Ishii test exhibited the highest sensitivity (71.59%) and specificity (90.48%) for probable sarcopenia (AUC: 0.810); it also showed 100% sensitivity and substantial specificity (78.57%, AUC: 0.893) for confirmed sarcopenia. Conclusion: Sarcopenia is highly prevalent in CLD patients, underscoring the need for routine screening. Among the screening tools, the Ishii test exhibited the highest diagnostic accuracy, making it a valuable tool for early detection. Routine assessment and targeted interventions for sarcopenia could improve functional outcomes in CLD patients. Cite this article as: Dilektasli AG, Kerimoğl D, Odabaş A, et al. Diagnostic performance of sarcopenia screening tests in chronic lung disease patients. Eurasian J Med. 2025;57(1), 0806, doi: 10.5152/eurasianjmed.2025.25806.

20 March 2019 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
PTPınar Taşar
Pınar Taşar
HTHalil Türkan
Halil Türkan
ZGZehra Gezer
Zehra Gezer
DKDemet Kerimoğlu
Demet Kerimoğlu
AKAdife Koç
Adife Koç
SKSadık Kılıçturgay
Sadık Kılıçturgay
Objective: Enteral nutrition (EN) is safe, well tolerated and efficient nutritional support for patients with functional gastrointestinal (GI) tract. The major problems of EN are intolerance of the nutrition products and problems of achieving the targeted dose. This is a prospective observational study investigating the nutrition related problems, solutions to those problems, and the time for achieving the targeted dose in patients who received EN in our inpatient clinic and intensive care unit. Methods: This prospective study was made between 11/01/2015-11/01/2016. This study evaluated patients demographic findings, nutrition status, daily calculated calories (25 kcal/kg/day), daily calculated protein dose (1.5 gr/kg/day), daily delivered calories, daily delivered protein dose, whether or not additional parenteral nutrition applied, biochemical parameters (blood sugar, Na, K, Ca, Mg, cholesterol, liver function tests, urea, CRP, albumin, prealbumin), intolerance issues, complications and EN termination reasons. Results: Considering 2258 patients hospitalized during this period, a total of 70 patients (3.1%) were applied EN (Female/Male: 30/40, The mean age of the patients was 60±16.5 years). The average application time is 11.5 (2-42) days. Among these patients, 26 had an NRS-2002 score ≥3, and only 6 had a BMI<18.8. The rate of calorie and protein application was lower than the calculated, respectively, 37.14% and 52.8% of the cases. It was observed that 40.54% of total malignant patients were subjected to immunonutrition. There were GI tract related problems in 20 patients. Diarrhea was the most important problem during enteral support. Oral supplementation intolerance problem was observed in 20% of the population. Hyperglycemia was detected in 35.7% of the patients, and more than half of them were between 200-300 mg/dL levels. Almost 53% of the patients had malignancy, however, only 5 of them had prescription for oral supplementation during discharge. Conclusion: EN was performed less than required with inaccurate calories and protein intake, and immunonutrition protocols in malignant patients are not properly complied and oral supplement prescription for those patients is rarely given after hospital discharge. Additionally, product intolerance is seriously frequent, and product and dosage changes should be done more actively.